Why don’t health plans voluntarily cover GLP-1s for obesity?
ICER found GLP-1 drugs to be cost effective for treating obesity. If that is the case, why don’t more US payers cover the GLP-1 drugs? Clearly, one reason is the cost given the sheer volume of patients i nthe US that are obese; specifically, >40% of US adults are obese. However, a bigger issue may…